Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids

Papers of special note have been highlighted as: • of interest

References

• 1. Carvalho S, Silveira MJ, Domingues M et al. Multicellular quadruple colorectal cancer spheroids as an in vitro tool for anti-angiogenic potential evaluation of nanoparticles. Adv. Ther. 6(4), 2200282 (2023).
  CASGoogle Scholar
• 2. Moreno-Londoño AP, Castañeda-Patlán MC, Sarabia-Sánchez MA et al. Canonical Wnt pathway is involved in chemoresistance and cell cycle arrest induction in colon cancer cell line spheroids. Int. J. Mol. Sci. 24(6), 5252 (2023).
  Medline CASGoogle Scholar
• 3. Blondy S, David V, Verdier M et al. 5-fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci. 111(9), 3142–3154 (2020). • Demonstrating how colon cancer resists 5-fluorouracil.
  Medline CASGoogle Scholar
• 4. Sousa-Squiavinato ACM, Arregui Ramos DA, Wagner MS et al. Long-term resistance to 5-fluorouracil promotes epithelial–mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Eur. J. Pharmacol. 933, 175253 (2022).
  Medline CASGoogle Scholar
• 5. Shakibaei M, Kraehe P, Popper B et al. Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer 15, 250 (2015).
  MedlineGoogle Scholar
• 6. Negrei C, Hudita A, Ginghina O et al. Colon cancer cells gene expression signature as response to 5-fluorouracil, oxaliplatin, and folinic acid treatment. Front. Pharmacol. 7, 172 (2016).
  MedlineGoogle Scholar
• 7. Gheytanchi E, Naseri M, Karimi-Busheri F et al. Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines. Cancer Cell Int. 21(1), 204 (2021).
  Medline CASGoogle Scholar
• 8. Yang L, Shi P, Zhao G et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Therap. 5(1), 8 (2020).
  MedlineGoogle Scholar
• 9. Azwar S, Seow HF, Abdullah M et al. Recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment. Biology (Basil) 10(9), 854 (2021).
  Medline CASGoogle Scholar
• 10. Patil K, Khan FB, Akhtar S et al. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer Metastasis Rev. 40(3), 691–720 (2021).
  MedlineGoogle Scholar
• 11. Ciccone V, Morbidelli L, Ziche M et al. How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance. Cancer Drug Resist. 3(1), 26–37 (2020). • Significance of ALDH1A1 in stemness, therapeutic resistance and metastasis.
  Medline CASGoogle Scholar
• 12. Wang W, He S, Zhang R et al. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin. Biomed. Pharmacother. 125, 109940 (2020). • Contribution of ALDH1A1 in stemness via activating AKT and Wnt/β-catenin pathways.
  Medline CASGoogle Scholar
• 13. Poturnajova M, Kozovska Z, Matuskova M. Aldehyde dehydrogenase 1A1 and 1A3 isoforms – mechanism of activation and regulation in cancer. Cell. Signal. 87, 110120 (2021). • Relation between ALDH1A and regulation of Wnt and NOTCH as well as downregulating ATP-binding cassette drug efflux.
  Medline CASGoogle Scholar
• 14. Wei Y, Li Y, Chen Y et al. ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front. Oncol. 12, 1026278 (2022).
  Medline CASGoogle Scholar
• 15. Zanoni M, Bravaccini S, Fabbri F et al. Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance. Front. Med. 9, 795762 (2022). • ALDH1A1 mediated cancer stem cells' chemoresistance-dependent reactive oxygen species.
  Google Scholar
• 16. Wang L, Wang X, Wang T et al. Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model. Bioresour. Bioprocess. 8, 135 (2021). • HIF-1A and ATP-binding cassette transporters mediated 5-fluorouracil resistance.
  CASGoogle Scholar
• 17. El Harane S, Zidi B, El Harane N et al. Cancer spheroids and organoids as novel tools for research and therapy: state of the art and challenges to guide precision medicine. Cells 12(7), 1001 (2023).
  MedlineGoogle Scholar
• 18. Zanoni M, Cortesi M, Zamagni A et al. Modeling neoplastic disease with spheroids and organoids. J. Hematol. Oncol. 13(1), 2020 (2020).
  Google Scholar
• 19. Jeppesen M, Hagel G, Glenthoj A et al. Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine. PLOS ONE 12(9), e0183074 (2017).
  MedlineGoogle Scholar
• 20. Zhang C, Liu X, Jin S et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21(1), 47 (2022). • Ferroptosis halts chemoresistance.
  MedlineGoogle Scholar
• 21. Chen Z, Wang W, Abdul Razak SR et al. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 14(7), 460 (2023).
  MedlineGoogle Scholar
• 22. Abu-Serie MM, Abdelfattah EZA. Anti-metastatic breast cancer potential of novel nanocomplexes of diethyldithiocarbamate and green chemically synthesized iron oxide nanoparticles. Int. J. Pharm. 627, 122208 (2022). • First in vitro and in vivo anti-breast cancer study declaring potency of FeO nanoparticles-diethyldithiocarbamate.
  Medline CASGoogle Scholar
• 23. Rahden-Staroń I, Grosicka-Maciąg E, Kurpios-Piec D et al. The effects of sodium diethyldithiocarbamate in fibroblasts V79 cells in relation to cytotoxicity, antioxidative enzymes, glutathione, and apoptosis. Arch. Toxicol. 86(12), 1841–1850 (2012). • Diethyldithiocarbamate as inhibitor of glutathione system.
  Medline CASGoogle Scholar
• 24. Vassalli G. Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells. Stem Cells Int. 2019, 3904645 (2019).
  MedlineGoogle Scholar
• 25. Abu-Serie MM, Abdelfattah AEZ. A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu₄O₃ nanoparticles or zinc oxide nanoparticles for efficient eradication of metastatic breast cancer. Sci. Rep. 13, 3529 (2023).
  Medline CASGoogle Scholar
• 26. Abu-Serie MM. Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells. Sci. Rep. 8(1), 4617 (2018).
  MedlineGoogle Scholar
• 27. Abu-Serie MM. Targeted ferroptotic potency of ferrous oxide nanoparticles-diethyldithiocarbamate nanocomplex on the metastatic liver cancer. Front. Pharmacol. 13, 1089667 (2023). • First in vitro and in vivo anti-liver cancer study demonstrating potency of FeO nanoparticles-diethyldithiocarbamate.
  MedlineGoogle Scholar
• 28. Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: implications for diagnosis and therapy. Oncol. Lett. 16(1), 9–18 (2018).
  MedlineGoogle Scholar
• 29. Oikonomou E, Makrodouli E, Evagelidou M et al. BRAF(V600E), efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells. Neoplasia 11(11), 1116–1131 (2009).
  Medline CASGoogle Scholar
• 30. Abu-Serie MM, El-Demellawy AM, El-Sayed M et al. In vitro sustained differentiation of rat colon epithelial stem cells. Biochem. Anal. Biochem. 5, 239 (2016).
  Google Scholar
• 31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65(1–2), 55–63 (1983).
  Medline CASGoogle Scholar
• 32. Longati P, Jia X, Eimer J et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13, 95 (2013).
  Medline CASGoogle Scholar
• 33. Bresciani G, Hofland LJ, Dogan F et al. Evaluation of spheroid 3D culture methods to study a pancreatic neuroendocrine neoplasm cell line. Front. Endocrinol. 10, 682 (2019).
  MedlineGoogle Scholar
• 34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976).
  Medline CASGoogle Scholar
• 35. Kernstock RM, Girotti AW. New strategies for the isolation and activity determination of naturally occurring type-4 glutathione peroxidase. Protein Expr. Purif. 62(2), 216–222 (2008).
  Medline CASGoogle Scholar
• 36. Ellman GL. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70–77 (1959).
  Medline CASGoogle Scholar
• 37. Innes GK, Fuller BJ, Hobbs KEF. Lipid peroxidation in hepatocyte cell cultures: modulation by free radical scavengers and iron. In Vitro Cell. Dev. Biol. 24, 126–132 (1988).
  Medline CASGoogle Scholar
• 38. Chen H, Wang C, Liu Z et al. Ferroptosis and its multifaceted role in cancer: mechanisms and therapeutic approach. Antioxidants (Basel) 11(8), 1504 (2022).
  Medline CASGoogle Scholar
• 39. Yu Y, Xie Y, Cao L et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol. Cell. Oncol. 2, e1054549 (2015).
  MedlineGoogle Scholar
• 40. Guo J, Xu B, Han Q et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res. Treat. 50(2), 445–460 (2018).
  Medline CASGoogle Scholar
• 41. Liu Q, Zhao Y, Zhou H et al. Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regen. Biomater. 10, rbad004 (2023).
  Medline CASGoogle Scholar
• 42. Yusefi M, Shameli K, Jahangirian H et al. The potential anticancer activity of 5-fluorouracil loaded in cellulose fibers isolated from rice straw. Int. J. Nanomed. 15, 5417–5432 (2020).
  Medline CASGoogle Scholar
• 43. Firuzi O, Che PP, El Hassouni B et al. Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells. Cancers (Basel) 11(5), 638 (2019).
  Medline CASGoogle Scholar
• 44. Moreno-Londoño AP, Robles-Flores M. Functional roles of CD133: more than stemness associated factor regulated by the microenvironment. Stem Cell Rev. Rep. 20(1), 25–51 (2024).
  Medline CASGoogle Scholar
• 45. Cosialls E, El Hage R, Dos Santos L et al. Ferroptosis: cancer stem cells rely on iron until ‘to die for’ it. Cells 10(11), 2981 (2021).
  Medline CASGoogle Scholar
• 46. Gui Y, Famurewa AC, Olatunji OJ. Naringin ameliorates 5-fluorouracil induced cardiotoxicity: an insight into its modulatory impact on oxidative stress, inflammatory and apoptotic parameters. Tissue Cell 81, 102035 (2023).
  Medline CASGoogle Scholar
• 47. Zhou P, Wang Z, Cheng C, Famurewa AC, Olatunji OJ. Naringin ameliorates 5-fluorouracil elicited neurotoxicity by curtailing oxidative stress and iNOS/NF-κB/caspase-3 pathway. Open Chem. 21(1), 20230126 (2023).
  CASGoogle Scholar
• 48. Suwannakot K, Sritawan N, Prajit R et al. Melatonin protects against the side-effects of 5-fluorouracil on hippocampal neurogenesis and ameliorates antioxidant activity in an adult rat hippocampus and prefrontal cortex. Antioxidants (Basel) 10(4), 615 (2021).
  Medline CASGoogle Scholar
• 49. Fideles LS, de Miranda JAL, Martins CDS et al. Role of rutin in 5-fluorouracil-induced intestinal mucositis: prevention of histological damage and reduction of inflammation and oxidative stress. Molecules 25(12), 2786 (2020).
  MedlineGoogle Scholar
• 50. van der Waals LM, Rinkes IHMB, Kranenburg O. ALDH1A1 expression is associated with poor differentiation, ‘right-sidedness’ and poor survival in human colorectal cancer. PLOS ONE 13, e0205536 (2018).
  MedlineGoogle Scholar
• 51. Croker AK, Rodriguez-Torres M, Xia Y et al. Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells. Int. J. Mol. Sci. 18, e2039 (2017).
  MedlineGoogle Scholar
• 52. Ren Y, Mao X, Xu H et al. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Cell. Mol. Life Sci. 80(9), 263 (2023).
  Medline CASGoogle Scholar
• 53. Liu W, Chakraborty B, Safi R et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat. Commun. 12(1), 5103 (2021).
  Medline CASGoogle Scholar